Available Technologies

Subcategories

Results found (126)
No.CategoryTechnology NameBriefcaseLead Researcher
612
Peptide-Based Induction of Bacterial Cell Death   Categories Antibacterial, Antibiotic, Sterilization Expected Impact The invention brings a new modality of anti-bacterial treatment as a stand-alone therapy or combined with antibiotics ...
More
Engelberg-Kulka Hanna
182
  Categories Life Science and Biotechnology Development Stage Proof-of-concept, in vitro Market Allergies, Asthma  Background Mast cells (MCs) are a type of white blood cell in the immune system. They are produced in the bone marrow and ...
More
Levi-Schaffer Francesca
4579
  Categories: Life sciences & Biotechnology Technology Keywords: Muscular dystrophy, nonsense mutation, Duchenne, Becker, cystic fibrosis, genetic diseases, dystrophin   Development Stage: Proof of concept  Our Innovation A nonsense ...
More
Karni Rotem
3177
  Categories Diagnostics,  Research Development Stage In vitro and in-vivo proof of concept; ongoing research Patent Status US, Europe and China applications filed based on WO 2017/025968  Background Fluorescence guided surgery is currently ...
More
Yavin Eylon
4247
  Categories Cannabinoids, Drug Delivery, Novel Carrier, Oral Formulation Development Stage In-vivo proof of concept Patent Status PCT patent application filed Market Improved delivery of cannabinoids is a real need and has an increasing ...
More
Touitou Elka
3171
  Categories Small molecules, anti-inflammatory treatment Development Stage In-vivo proof of concept Patent Status Patent application filed Market Inflammation indications: acute pancreatitis, acute live damage, fatty liver damage, ...
More
Weinstock-Rosin Marta
4448
  Categories Cannabinoid Administration, Formulation, Drug Delivery, Novel Carriers, Transdermal Formulation, Nasal Formulation, Oral formulation Development Stage In-vivo proof of concept Patent Status Several patent applications – new ...
More
Touitou Elka
4334
Oral Dosage Form for Immediate and Prolonged Action of Cannabinoids     Categories  Cannabinoids, Drug Delivery, Novel Carrier, Oral Formulation Development Stage In-vivo proof of concept Patent Status PCT patent application filed Market ...
More
Touitou Elka
2338
  A non-invasive alternative to injection, by enhancing gastric absorption   Categories Oral drug-delivery, non-invasive drug administration, gastric absorption, peptide oral formulation, tight junctions (TJs), biopharmaceutical drugs, oral ...
More
Ben-Sasson Shmuel
577
Prof. Yaron Ilan, Department of Human Nutrition and Metabolism and Liver Unit Hadassah Hospital Cannabinoids/endocannabinoids and/or capsaicin or cannabidiol, improve both liver and brain functions   Categories Nutrition and Metabolism, ...
More
Avraham Yosefa
4213
Highly sensitive self formed and simple to fabricate nano junction devices that change resistance in the presence of minute concteration of volatile gases.  Patent Status   PCT  application filed.   Highlights Detectors of volatile gas, ...
More
Yerushalmi Roie
3107
  Categories Treatment of cancer, neurodegeneration and infectious diseases. Development Stage In vitro proof of concept; in vivo POC Patent Status PCT publication number : WO2016/142948Highlights A new technology to inhibit the activity ...
More
Karni Rotem
2622
A specific therapy for treating this serious disease   Categories Mastocytosis, Cancer Development Stage Proof-of-concept, preclinical Patent Status Patent Pending Market Mastocytosis, Mast Cell Leukemia, AllergiesBackground Mast cells ...
More
Levi-Schaffer Francesca
4305
  Simplifies evaluation of treatment progress   Categories Oncology/Cancer, Medical Applications Development Stage Proof of concept completed; ongoing research with larger data sets Patent Status Provisional patent application ...
More
Joskowicz Leo
4377
Additional information will be provided upon request
More
Friedman Michael
4303
Keywords Drug Delivery, Formulation Current development stage TRL7, Prototype and proprietary list of approved drugs that benefit from liposomal formulationsApplication Most active pharmaceutical ingredients (APIs) are not suitable for ...
More
Barenholz Yechezkel
4550
Additional information will be provided upon request
More
Yirmiya Raz
4430
Additional information will be provided upon request
More
Domb Abraham
4530
Additional information will be provided upon request
More
Friedman Nir
2155
Additional information will be provided upon request
More
Yitzchaik Shlomo